World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
49841
World Ranking
12903
National Ranking
6595

Overview

Brian P. Rubin is affiliated with the Cleveland Clinic in the United States and has an extensive publication record in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research primarily focuses on subfields including Pulmonary and Respiratory Medicine, Oncology, Rheumatology, Molecular Biology, and Infectious Diseases.

Their main research topics cover diverse areas such as:

  • Sarcoma Diagnosis and Treatment
  • Vascular Tumors and Angiosarcomas
  • Soft tissue tumor case studies
  • Hippo pathway signaling and YAP/TAZ
  • Ubiquitin and proteasome pathways
  • Gastrointestinal Tumor Research and Treatment
  • Cardiac tumors and thrombi

Brian P. Rubin frequently publishes in a range of scientific venues. These include:

  • Modern Pathology
  • Histopathology
  • Clinical Cancer Research
  • Journal of Cutaneous Pathology
  • Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin

The scientist has collaborated multiple times with several co-authors, including:

  • Josephine K. Dermawan
  • Steven D. Billings
  • Karen Fritchie
  • Jennifer S. Ko
  • Ajaybabu V. Pobbati

Some of their recent papers include:

  • "NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021" (2020), published in Journal of the National Comprehensive Cancer Network
  • "Individualizing Risk Prediction for Positive Coronavirus Disease 2019 Testing" (2020), published in CHEST Journal
  • "Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts" (2021), published in ESMO Open
  • "Alpha to Omicron: Disease Severity and Clinical Outcomes of Major SARS-CoV-2 Variants" (2022), published in The Journal of Infectious Diseases
  • "Therapeutic targeting of TEAD transcription factors in cancer" (2023), published in Trends in Biochemical Sciences

Best Publications

  • Diagnosis of gastrointestinal stromal tumors: A consensus approach.

    Christopher D.M. Fletcher;Jules J. Berman;Christopher Corless;Fred Gorstein

  • Guidelines for the use and interpretation of assays for monitoring autophagy

    Daniel J. Klionsky;Fabio C. Abdalla;Hagai Abeliovich;Robert T. Abraham

  • KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.

    Brian P. Rubin;Samuel Singer;Connie Tsao;Anette Duensing

  • Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas

    Adam Abeshouse;Clement Adebamowo;Sally N. Adebamowo;Rehan Akbani

  • Gastrointestinal stromal tumour

    Brian P Rubin;Michael C Heinrich;Michael C Heinrich;Christopher L Corless;Christopher L Corless

  • The Novel Marker, DOG1, Is Expressed Ubiquitously in Gastrointestinal Stromal Tumors Irrespective of KIT or PDGFRA Mutation Status

    Robert B. West;Christopher L Corless;Xin Chen;Brian P. Rubin

  • TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors.

    Brandon Lawrence;Antonio Perez-Atayde;Michele K. Hibbard;Brian P. Rubin

  • KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors.

    Marcia L. Lux;Brian P. Rubin;Tara L. Biase;Chang Jie Chen

  • KIT Gene Mutations and Copy Number in Melanoma Subtypes

    Carol Beadling;Erick Jacobson-Dunlop;F. Stephen Hodi;Claudia Le

  • Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature.

    Andrew L. Folpe;Julie C. Fanburg-Smith;Steven D. Billings;Michele Bisceglia

  • Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations.

    Michael C. Heinrich;Brian P. Rubin;B.Jack Longley;Jonathan A. Fletcher

  • Prognostic Value of KIT Mutation Type, Mitotic Activity, and Histologic Subtype in Gastrointestinal Stromal Tumors

    Samuel Singer;Brian P. Rubin;Marcia L. Lux;Chang Jie Chen

  • A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells.

    Robert B. West;Brian P. Rubin;Melinda A. Miller;Subbaya Subramanian

  • A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors.

    Inigo Espinosa;Cheng Han Lee;Mi Kyung Kim;Bich Tien Rouse

  • Human cancers express a mutator phenotype

    Jason H. Bielas;Keith R. Loeb;Brian P. Rubin;Lawrence D. True

  • Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases.

    Andrew L Folpe;John R Goldblum;Brian P Rubin;Bahig M Shehata

  • Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans.

    Brian P. Rubin;Scott M. Schuetze;Janet F. Eary;Thomas H. Norwood

  • Congenital Mesoblastic Nephroma t(12;15) Is Associated with ETV6-NTRK3 Gene Fusion Cytogenetic and Molecular Relationship to Congenital (Infantile) Fibrosarcoma

    Brian P. Rubin;Chang Jie Chen;Chang Jie Chen;Thomas W. Morgan;Sheng Xiao;Sheng Xiao

  • Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials

    Piotr Rutkowski;Martine Van Glabbeke;Cathryn J Rankin;Wlodzimierz Ruka

  • Prognostic V alue o f KIT Mutation T ype, M itotic A ctivity, and H istologic S ubtype i n G astrointestinal S tromal Tumors

    Samuel Singer;Brian P. Rubin;Marcia L. Lux;Chang-Jie Chen

Frequent Co-Authors

John R. Goldblum
John R. Goldblum Cleveland Clinic
Jonathan A. Fletcher
Jonathan A. Fletcher Brigham and Women's Hospital
Christopher L. Corless
Christopher L. Corless Oregon Health & Science University
Christopher D.M. Fletcher
Christopher D.M. Fletcher Brigham and Women's Hospital
Michael Heinrich
Michael Heinrich Oregon Health & Science University
Tamas Ordog
Tamas Ordog Mayo Clinic
Alexander J. Lazar
Alexander J. Lazar The University of Texas MD Anderson Cancer Center
Jorge S. Reis-Filho
Jorge S. Reis-Filho Memorial Sloan Kettering Cancer Center
Robert B. West
Robert B. West Stanford University
Matt van de Rijn
Matt van de Rijn Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Many students interested in medicine also consider alternative or supplemental healthcare degrees. Online learning options have expanded rapidly, making it easier to advance your education while balancing personal and professional commitments.

For those seeking a leadership role in healthcare, online mha programs offer a pathway to hospital administration and healthcare management jobs. Nurses looking to further their careers can advance with a BSN, and may wonder, does rn to bsn require clinicals—some programs offer flexible options that can minimize or waive clinical components.

Ambitious nursing professionals might choose to pursue a Doctor of Nursing Practice (DNP). If you're looking for accelerated options, explore a 1 year dnp program online for a quicker path to advanced practice roles. There are also various online dnp programs designed to be more accessible and manageable for working nurses.

These related degrees can open doors to diverse and rewarding careers across the healthcare landscape, proving that there are multiple routes to making a meaningful impact in medicine.

Best Scientists Citing Brian P. Rubin

Trending Scientists

Recently Published Articles